cephalosporin c has been researched along with Non-alcoholic Fatty Liver Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chu, H; Dang, Y; Li, P; Xing, M; Xu, X; Xue, H; Zhang, N; Zhang, W; Zheng, Z; Zhou, C | 1 |
1 other study(ies) available for cephalosporin c and Non-alcoholic Fatty Liver Disease
| Article | Year |
|---|---|
7-aminocephalosporanic acid, a novel HSP90β inhibitor, attenuates HFD-induced hepatic steatosis.
Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Diet, High-Fat; Lipogenesis; Liver; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Triglycerides | 2022 |